异质表达和优化发酵条件用于重组伊卡鲁加辛的生产
Julia K Evers1, Anna Glöckle1, Monique Wiegand1
1Chair of Technical Biochemistry, Technische Universität Dresden, Dresden, Saxony, Germany.
Biotechnology and bioengineering
|January 12, 2025
概括
研究人员开发了一种具有成本效益的方法来生产Ikarugamycin,这种天然化合物具有多种生物医学应用. 这个新平台的产量超过100mg/L,使这个有价值的研究工具更容易获得科学研究.
科学领域:
- 自然产品化学 自然产品化学
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伊卡鲁加氨酸属于自然产品的多环四甲基麦克罗拉克坦 (PoTeMs) 家族.
- 它具有广泛的生物活性,包括抗微生物,抗原动物,抗白血病和抗炎作用.
- 伊卡鲁加氨酸是一种有价值的工具化合物,用于研究细胞过程,如脂蛋白吸收和内细胞分裂,但其高成本限制了研究应用.
研究的目的:
- 开发一个高收益的重组生产平台,用于Ikarugamycin.
- 为了克服高商业价格的Ikarugamycin所带来的局限性.
- 通过具有成本效益的生产,使伊卡鲁加辛在生物医学研究中得到更广泛的使用.
主要方法:
- 对各种表达载体和复合宿主菌株的查.
- 优化用于重组生产的种植条件.
- 开发一种简单的净化方案,用于生产的Ikarugamycin.
主要成果:
- 实现过度生产水平超过100 mg/L的Ikarugamycin.
- 建立了一个高收益的重组生产平台.
- 为目标化合物开发了一种高效的净化方法.
结论:
- 生物技术生产提供了负担得起的Ikarugamycin.
- 开发的平台显著降低了ikarugamycin的成本.
- 增加Ikarugamycin的可用性将促进其在生物医学研究中的使用.
相关概念视频
01:29Microbes in Food Production
Microbial fermentation is central to food biotechnology, enhancing flavor, texture, preservation, and stability. Fermentative microorganisms metabolize carbohydrates into organic acids, alcohols, and other metabolites that inhibit spoilage organisms and improve digestibility while contributing distinctive sensory qualities.In baking, amylases naturally present in flour hydrolyze starch into monosaccharides such as glucose, which Saccharomyces cerevisiae ferments anaerobically. Through...
01:22Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:27Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...